PEXA GROUP LIMITED — Director's Dealing 2023

Dec 5, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PEXA Group Limited ABN 23 629 193 764

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Glenn King
Date of last notice	20 December 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest	N/A
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change	1 December 2023
No. of securities held prior to change	1,115,637 Ordinary Shares
	58,176 Performance Rights under the
	PEXA Group Limited Equity Plan with a
	performance period 1 July 2021 – 30 June
	2024.
	63,435 Performance Rights under the
	PEXA Group Limited Equity Plan with a
	performance period 1 July 2022 – 30 June
	2025.
Class	Performance Rights
Number acquired	86,417

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation	The Performance Rights were grantedunder the PEXA Group Limited EquityIncentive Plan for no consideration.As set out in the 2023 Notice of AGM, thenumber of Performance Rights grantedwas based on Glenn King’s maximum LTIopportunity of 100% of fixed annualremuneration of $991,000 divided by the10-day VWAP of shares for the periodcommencing on the second trading dayafter the Company’s Annual Report forFY23 was released to the market.
No. of securities held after change	1,115,637 Ordinary Shares58,176 Performance Rights under thePEXA Group Limited Equity Plan with aperformance period 1 July 2021 – 30 June2024.63,435 Performance Rights under thePEXA Group Limited Equity Plan with aperformance period 1 July 2022 – 30 June2025.86,417 Performance Rights under thePEXA Group Limited Equity Plan with aperformance period 1 July 2023 – 30 June2026.
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back	Issue of Performance Rights under PEXAGroup Limited Equity Incentive Plan.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?
If prior written clearance was provided, on what date wasthis provided?

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3